Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.
Twitter handle: @jeffmason1
WASHINGTON/LOS ANGELES The U.S. Food and Drug Administration is considering a ban on flavored e-cigarettes from Juul Labs and other companies as it grapples with an "epidemic" of youth e-cigarette use that threatens to create a new generation of nicotine addicts, the agency's head said on Wednesday. | Video
WASHINGTON U.S. Health and Human Services Secretary Alex Azar said it was within his agency's power to eliminate rebates on prescription drug purchases, a key element of the Trump administration's plan to lower prescription medicine costs. | Video
WASHINGTON, Aug 20 U.S. Health and Human Services Secretary Alex Azar said it was within his agency's power to eliminate rebates on prescription drug purchases, a key element of the Trump administration's plan to lower prescription medicine costs.
Merck & Co on Thursday announced price cuts to some of its medicines, including a 60 percent reduction to a hepatitis C treatment, after U.S. President Donald Trump criticized drugmakers for failing to help reduce healthcare costs for consumers.
July 19 Merck & Co on Thursday announced price cuts to some of its medicines, including a 60 percent reduction to a little-used hepatitis C treatment, after U.S. President Donald Trump criticized drugmakers for failing to help reduce healthcare costs for consumers.
NEW YORK/WASHINGTON U.S. President Donald Trump called Pfizer Chief Executive Ian Read on Tuesday to say the company's July 1 price hikes had complicated the administration's drug pricing plans, prompting the company to defer its planned increases, according to a source familiar with the matter.
WASHINGTON/NEW YORK Pfizer Inc said on Tuesday it was deferring drug price increases for no more than six months after the company's chief executive officer had an extensive conversation with U.S. President Donald Trump.
EARLE, Arkansas Gregory Tyrone Bryant left his last stable job at a meatpacking factory to fight a cocaine addiction eight years ago. When he returned to the workforce a year later, his options were limited: mostly temporary jobs without healthcare benefits. | Video
BOSTON/WASHINGTON A U.S. federal judge on Friday blocked Kentucky from implementing work requirements in its Medicaid program, potentially dealing a blow to the Trump administration's effort to scale back the 50-year-old health insurance program for the poor and disabled.
NEW YORK, June 19 The Trump administration on Tuesday issued a finalized rule that will enable millions of Americans to buy skimpy health insurance plans that do not comply with key Obamacare coverage requirements, marking its latest effort to chip away at the healthcare law.
- Gold: PRECIOUS-Gold prices edge up as easing trade concerns hurt dollar
- Oil Report: UPDATE 4-Oil steady, supported by U.S. stocks and supply concerns
- British Pound Report: UPDATE 1-Sterling extends gains after forecast-beating retail sales
- US Dollar Report: FOREX-Dollar stuck near seven-week low as trade war fears fade